Rachel Ee

Academic and researcher in the development of novel biotherapeutics and hydrogel formulations for delivery of drugs, genes and cells; Champions academic-industry partnerships for synergy in education and research.

Teaching Activities in NUS

• Dosage form design, pharmaceutics and pharmaceutical biotechnology.

Research Interests

Cancer therapeutics

• Role of secreted Wnt antagonists in osteosarcoma progression
• Screening, characterization and structure-activity relationship studies of potent antagonists of the Wnt/β-catenin signaling pathway

Novel delivery systems

• Novel hybrid PEG-peptide hydrogels for stem cell delivery in cartilage repair
• Cationic polymers for DNA/siRNA/miRNA delivery
• Antimicrobial peptides for TB therapy

Education

• Doctor of Philosophy (Ph.D.) University of Illinois at Chicago (2000 — 2004)
• The Cambridge Negotiations Lab Cambridge Judge Business School (2018 — 2018)
• UCLA Anderson School of Management (2014 — 2014)
• Bachelor of Science - BSc (Pharmacy) (Hons) National University of Singapore (1994 — 1998)

Companies

• Editorial Board Member Chemical Engineering Research and Design by Elsevier (2021)
• University Mid-term Advisory Review Committee National University of Singapore (2021)
• Deputy Head Of Department (Research) National University of Singapore (2018)
• Director of Pharmaceutical Sciences Programme National University of Singapore (2018)
• Faculty Promotion & Tenure (Junior) Committee National University of Singapore (2018)
• Associate Professor National University of Singapore (2015)
• Senate Delegacy Member National University of Singapore (2017 — 2021)
• University Mid-Term Advisory Review Committee National University of Singapore (2017 — 2018)
• Assistant Professor National University of Singapore (2006 — 2014)